Based on 3 analysts giving stock ratings to IN8BIO, Inc. in the past month.
In the current month, INAB has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. INAB average Analyst price target in the last month is 7.000.
Based on analysts' estimates, INAB EPS is projected to reach -0.350 in FY2026Q4, following reported EPS of -0.236 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.24, while IN8BIO, Inc.INAB's earnings per share (EPS) for the previous quarter was USD -0.25. EPS for the next quarter is expected at USD -0.35.